In Addition, IL‐12 and Th1‐derived IFN‐γ exerted antitumor effects through the inhibitory effects of endogenous CXCL9 and CXCL10 on tumor vasculature in human Burkitt's lymphoma 51 and in B‐cell lymphoma 52, respectively. The gene discussed is CXCL10; the disease is neoplasm.